By using IL-17RA−/−mice, the authors of one study reported that IL-17RA signaling regulated liver injury in the progression of NAFLD; the neutralization of IL-17A, meanwhile, significantly reduced obesity-driven hepatocellular damage. This evidence concerns the gene IL17RA and obesity due to melanocortin 4 receptor deficiency.